Epithelial ovarian cancer with neoadjuvant chemotherapy
This study performed bulk RNA-seq analysis on tumor samples from 83 epithelial ovarian cancer patients, collected both before and after neoadjuvant chemotherapy (NACT), to uncover the molecular mechanisms underlying NACT efficacy.